Plasma Aldosterone and Glomerular Filtration in Hypertensive Patients With Preserved Renal Function;Aldosterona plasmática y filtrado glomerular en el paciente hipertenso con función renal conservada

Revista Espanola de Cardiologia

Volumn 63, Issue 1, 2010, Pages 103-106

  Roldán, Julián ^a   Morillas, Pedro ^a   Castillo, Jesús ^a   Andrade, Helder ^a   Guillén, Silvia ^a   Núñez, Daniel ^a   Quiles, Juan ^a   Bertomeu, Vicente ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

Aldosterone; Kidney; Systemic arterial hypertension

Indexed keywords

ALDOSTERONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE;

ALDOSTERONE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 76749158802     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70015-4     Document Type: Article

References (11)

1. Yoshimoto T., and Hirata Y. Aldosterone as a cardiovascular risk hormone. Endocr J 54 (2007) 359-370
2. Morillas P., Castillo J., Quiles J., Núñez D., Guillén S., Bertomeu-González V., et al. Prevalencia y afectación cardiaca del hiperaldosteronismo en el paciente hipertenso. Rev Esp Cardiol 61 (2008) 418-421
3. Ibrahim H.N., and Hostetter T.H. Aldosterone in renal disease. Curr Opin Nephrol Hypertens 12 (2003) 159-164
4. Wenzel U. Aldosterone and progression of renal disease. Curr Opin Nephrol Hypertens 17 (2008) 44-50
5. Rossi G.P., Bernini G., Desideri G., Fabris B., Ferri C., Ganzardi C., et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48 (2006) 232-238
6. Milliez P., Girerd X., Plouin P.F., Blacher J., Safar M.E., Mourad J., et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45 (2005) 1243-1248
7. Vasan R.S., Evans J.C., Larson M.G., Wilson P.W., Meigs J.B., Rifai N., et al. Aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351 (2004) 33-41
8. Shibata S., Nagase M., Yoshida S., Kawachi H., and Fujita T. Podocyte as the target for aldosterone: Roles of oxidative stress and Sgk1. Hypertension 49 (2007) 355-364
9. Miyata K., Rahman M., Shokoji T., Nagai Y., Zhang G.X., Sun G.P., et al. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 16 (2005) 2906-2912
10. Terada Y., Kuwana H., Kobayashi T., Okado T., Suzuki N., Yoshimoto T., et al. Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. J Am Soc Nephrol 19 (2008) 298-309
11. Marney A.M., and Brown N.J. Aldosterone and end-organ damage. Clin Sci (Lond) 113 (2007) 267-278